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ABSTRACT The chaperonin GroEL is a large complex
composed of 14 identical 57-kDa subunits that requires ATP
and GroES for some of its activities. We find that a monomeric
polypeptide corresponding to residues 191 to 345 has the
activity of the tetradecamer both in facilitating the refolding
of rhodanese and cyclophilin A in the absence of ATP and in
catalyzing the unfolding of native barnase. Its crystal struc-
ture, solved at 2.5 Å resolution, shows a well-ordered domain
with the same fold as in intact GroEL. We have thus isolated
the active site of the complex allosteric molecular chaperone,
which functions as a “minichaperone.” This has mechanistic
implications: the presence of a central cavity in the GroEL
complex is not essential for those representative activities in
vitro, and neither are the allosteric properties. The function of
the allosteric behavior on the binding of GroES and ATP must
be to regulate the affinity of the protein for its various
substrates in vivo, where the cavity may also be required for
special functions.
The molecular chaperone GroEL facilitates the folding of
some proteins (1). GroEL is composed of 14 identical 57-kDa
subunits that form two rings with 7-fold symmetry, each with
a central cavity. Each GroEL subunit in the 2.8 Å crystal
structure has three domains (2, 3). Mutations in the apical
domain lead to a decrease in polypeptide binding (4), suggest-
ing that this domain is involved in the binding of polypeptides.
Electron microscopy suggests that denatured protein binds to
the inner side of the apical end of the GroEL-cylinder (5). The
equatorial domain has been shown from the 2.4 Å crystal
structure of ATP[gS]-ligated GroEL (6) and mutagenesis
studies (4) to contain the nucleotide binding sites. Binding and
hydrolysis of ATP is cooperative (7, 8) and lowers the affinity
for polypeptides (9). Most of the intermolecular contacts
between the subunits of GroEL are between the equatorial
domains. The intermediate domain connects the other two
domains, transmitting allosteric effects (2, 3).
Two features of the complex are usually assumed to be the
keys to its activity: (i) the central cavity, which can act as a cage
for folding, and (ii) the allosteric switching of GroEL from a
state that has a high affinity for denatured peptides to one that
has a low affinity on the binding of ATP and GroES (10, 11).
It has been argued that the primary function of GroEL is to
provide a cage in which a protein can fold in isolation (1),
which has been supported by the finding that small proteins can
fold fully while bound to GroEL (12). It has also been shown
that GroEL can catalyze the unfolding of one of these proteins,
barnase (10), which supports the idea of an annealing activity
that causes misfolded proteins to unfold and then have further
attempts at productive folding (13, 14) It has been suggested
that the role of GroEL in vivo is to provide a combination of
cage and annealing activities, with the allosteric switching
controlling the balance of activities and the entry to the
chaperoning cycle (15).
Does GroEL have to be a complex multimer to be func-
tional? Is there a small part of GroEL that is responsible for
its activity, while the rest of the protein is present for regulation
and other biological functions? Yoshida and coworkers (16,
17) have reported that a 34-kDa proteolytic fragment of
GroEL (GroEL150-456) and a 50-kDa fragment of cpn60 from
Thermus thermophilus facilitate refolding of denatured rho-
danese in the absence of GroES and ATP. In contrast,
monomeric forms of GroEL that have been induced by site-
directed mutagenesis do not affect the refolding of rhodanese
(18). Further, monomers of GroEL can be induced by urea,
treatment with ion-exchange resin, or pressure, but they are
able to facilitate the refolding of rhodanese only after reas-
sociation to form the central cavity (19–21). Although the
proteolytic fragment GroEL150-456 elutes as a monomer
during gel filtration (16), it contains parts of the intermediate
and equatorial domains, which determine the intersubunit
contacts of GroEL (2), and could thus be capable of transient
formation of oligomers or even the central cavity.
To investigate these and other questions, we have function-
ally expressed the apical domain of GroEL and various of its
fragments in Escherichia coli, allowing us to study the chap-
erone activity, folding, and crystal structure of the polypeptide
binding domain in isolation.
MATERIALS AND METHODS
Production of Fragments. The apical domain of GroEL
(GroEL191-376) (2) and the various C-terminally truncated
fragments of the apical domain were cloned by polymerase
chain reaction (PCR) into the polylinker site of a pRSET A
vector (Invitrogen), coding for an N-terminal histidine-tail,
which contained an engineered thrombin cleavage site (M.
Proctor and M. Bycroft, unpublished work) as in Fig. 1. The
histidine-tail (ht) was composed of 36 amino acids (Invitrogen)
or 17 amino acids (sht; M. Proctor andM. Bycroft, unpublished
work). For the PCR reaction, we used the plasmid pOF39 (24)
as a template and two primers flanking the respective GroEL
fragment with BamHI and EcoRI restriction enzyme sites,
which enabled us to clone the PCR fragment into the
polylinker of pRSET A. PCR was performed with Pfu (Strat-
agene) to reduce the risk of undesired random mutations. The
reaction was performed in 25-ml vol for 25 cycles with 400 nM
primer and 200 mM each dNTP. The annealing temperature
was 658C. The following primers were used for the PCR:
59-f lanking, 59-CGG ATC CGA AGG TAT GCA GTT CGA
CCG; 39-f lanking (s)ht-GroEL191-376, 59-CGA ATT CTT
AAA CGC CGC CTG CCA GTT TCG; 39-f lanking (s)ht-
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GroEL191-345, 59-CGA ATT CTT AAC GGC CCT GGA
TTG CAG CTT C; 39-f lanking ht-GroEL191-337, 59-CGA
ATT CTT AAC CCA CGC CAT CGA TGA TAG TGG TG;
39-f lanking ht-GroEL191-328, 59-CGA ATT CTT AGT CTT
TGTTGATCACAACACGTTTAGCCTGAC; 39-f lanking
ht-GroEL191-322, 59-CGA ATT CTT AAC GTT TAG CCT
GAC CCA GGT CTT CCA; 39-f lanking ht-GroEL191-298,
59-CGA ATT CTT AAC CGC CAG TCA GGG TTG CGA
TAT C. The following protocol was used for expression and
purification of the fragments of GroEL in E. coli TG2 cells.
Two liters of Luria broth medium plus ampicillin were inoc-
ulated 1:100 with an overnight culture of TG2 cells containing
the respective plasmid. At OD600 5 0.3, expression was in-
duced with isopropyl b-D-galactopyranoside (IPTG) to 0.2
mM final concentration andM13yT7-phage at a multiplicity of
infection of 10 phage per cell. The cells were harvested 8 h
after induction, centrifuged, and resuspended in 200 ml buffer
A (50 mM TriszHCl, pH 8.2y300 mM NaCl). After sonication
and centrifugation, the soluble protein fraction was added to
20 ml nickel-NTA agarose resin and stirred for 10 min. The
resin was washed with 200 ml buffer A, and the histidine-tail
containing fusion protein was eluted with 50 ml buffer A
containing 200 mM imidazole. The eluted protein was precip-
itated with 80% ammonium sulfate, redissolved in 4 ml of
buffer B (50 mM TriszHCl pH 8.2y150 mM NaCl), and was
loaded on a HiLoad 26y60 Superdex 75 column (Pharmacia)
that was equilibrated with buffer B. The fragment GroEL191-
345 was produced by thrombin-cleavage of ht-GroEL191-376
before gel filtration. The cleaving reaction was carried out for
several days in buffer B after addition of 250 ml of thrombin
(Sigma, 1 unityml) to the protein solution eluted from the
nickel-NTA column. The GroEL fragments were analyzed by
quantitative amino acid analysis, N-terminal sequencing, and
mass spectrometry. Our clone differs from the sequence in the
data base by the mutations Leu-2623Ala andMet-2673 Ile.
Crystallization, Data Collection, and Solution of Structure.
Crystals were obtained from hanging drops initially containing
sht-GroEL191-345 at 23 mgzml21, 11% PEG 4000, 50 mM
TriszHCl (pH 8.5), and 100 mM LiSO4, equilibrated against
reservoirs consisting of 22% PEG 4000, 100 mM TriszHCl (pH
8.5), and 200 mM LiSO4. X-ray data were collected from a
capillary-mounted crystal at 48C using a 30-cmMARResearch
(Hamburg) image plate detector at station 9.6 of the Synchro-
tron Radiation Source at Daresbury, U.K. (l 5 0.87 Å). Unless
stated otherwise, all data processing, data reduction, electron
density syntheses, and structural analyses were carried out
using CCP4 software (Daresbury Laboratory, Warrington,
U.K.). Indexing and intensity measurements of diffraction
data were carried out with the MOSFLM program suite (25).
The asymmetric unit contains one protein molecule, corre-
sponding to a solvent content of 51%. The structure was solved
by conventional molecular replacement methods, using the
program AMORE (26), and a search model consisting of resi-
dues 191–345 of the refined structure of GroEL (3). Model
rebuilding was carried with the program O (27), and the structure
was refined using X-PLOR (28) using Engh and Huber parameters
(29). The current model contains eight water molecules and is
complete with the following exceptions, which could not be
modeled due to poor or nonexistent electron density: residues
302–307 and residues 337–345 from the C terminus. Electron
density for the N-terminal His-tag is also not observed. No
residues have disallowed backbone f,c angles.
NMR. Exchange experiments were carried out at 338C in 20
mM imidazole buffer as described (10, 11).
Refolding Experiments.Refolding assay of rhodanese was as
described by Horowitz (30). To stop the refolding reaction in
the kinetic experiments, rhodanese activity was assayed in the
presence of 10 mM trans-1,2-cyclohexanediaminetetraacetate
to inhibit GroEL activity or 0.5 mgyml of casein to saturate the
apical domain. Refolding of cyclophilin A was initiated by
diluting 8 M urea denatured protein (100 mM) into 100 mM
potassium phosphate buffer (pH 7.0) and 10 mM DTT to a
final concentration of 1 mM. The final concentration of GroEL
and apical domain in refolding buffer was 7 mM and 4 mM or
1 mM, respectively. Refolding temperature was 258C. After
incubation for the times indicated, cyclophilin activity was
measured as described (36). Spontaneous refolding of cyclo-
philin A occurred to a yield of about 30%, and was finished in
less than 1 min. Standard error was 5%.
Thermal Denaturation Experiments. Thermal denaturation
was measured with a Jasco (Easton, MD) model J720 spec-
tropolarimeter interfaced with a Neslab Instruments (Ports-
mouth, NH)model RTE-110 water bath, using a thermostatted
cuvette of 1-mm path length. The temperature was increased
FIG. 1. Cloning of the apical domain of GroEL and various of its fragments. The utilized expression vector coded for an N-terminal histidine-tail
(ht) composed of 36 amino acids and containing a thrombin cleavage site (vertical arrow). Alternatively, a shorter version of this histidine-tail (sht)
containing 17 amino acids was used. The N and C termini of the generated fusion proteins, namely ht-GroEL191-298, ht-GroEL191-322,
ht-GroEL191-328, ht-GroEL191-337, ht-GroEL191-345, ht-GroEL191-376, sht-GroEL191-345, and sht-GroEL191-376 are indicated by horizontal
arrows. Secondary structure is indicated by boxes and arrows for a-helix (shaded) or 310-helix (open) and b-sheet structure, respectively. Assignment
of secondary structure of residues 191 to 336 was from the crystal structure of sht-GroEL191-345 using PROCHECK (22) and the algorithm of Kabsch
and Sander (23). Numbering of a-helices and secondary assignment of residues 337 to 376 according to Braig et al. (3).
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at a linear rate of 508C per h. The protein concentration was
40 mM in 10 mM sodium phosphate buffer (pH 7.0). Data were
fitted to a denaturation curve to determine Tm, the midpoint
temperature of denaturation. Differential scanning calorimet-
ric measurements were performed at a protein concentration
of 88 6 5 mM in 10 mM sodium phosphate buffer (pH 7.0),
using a Microcal (Amherst, MA) model MC-2D instrument at
a notional scan rate of 608C per h. Sample preparation and
data analysis were performed as described previously (31).
Both proteins exhibit at least 50% reversibility in their thermal
unfolding as judged from the area of endotherms obtained on
rescanning samples. Higher levels of reversibility were obtained
at lower concentrations or by stopping scans at temperatures
closer to the main unfolding transition. The low temperature
transition observed in sht-GroEL191-376 was completely revers-
ible with scans limited to temperatures below 508C.
RESULTS
Expression of Fragments. The apical domain is expressed at
.20 mg purified protein per liter of culture as are the smaller
fragments lacking the C-terminal a-helices, H11, and H12.
Further truncation before residue 329 leads to considerable
destabilization of the apical domain. The fragment GroEL191-
345, which is preceded by Gly-Ser and lacks the two C-terminal
helices, was generated by thrombin cleavage of purified ht-
GroEL191-376. The circular dichroism (CD) of sht-
GroEL191-376, sht-GroEL191-345, and GroEL191-345 indi-
cated native-like secondary and tertiary structure (data not
shown). The apical domain and the fragment truncated at
position 345 are monomeric at micromolar concentrations, as
determined by ultracentrifugation experiments (R.Z., S. E. Har-
ding, and A.R.F., unpublished work). However, the line widths in
the NMR spectra of GroEL191-345 at higher concentration are
larger than expected for a 17-kDa protein but smaller than for a
stable dimer (data not shown), indicating a fast intermolecular
interaction between monomers on the NMR time scale (32).
Chaperone Activity of Monomeric Fragments. The GroEL
fragments catalyze, under folding conditions, exchange of
amide protons of native barnase (Fig. 2) that are known to
exchange only from its fully unfolded state. Thus, like intact
GroEL (10), the apical domain binds with high affinity to
unfolded barnase. Helices H11 and H12 are not essential for
polypeptide binding, and the presence of the N-terminal
FIG. 2. Catalysis of amide proton exchange of barnase (2.4 mM) by
the fragments GroEL191-345 (a) and sht-GroEL191-376 (b). The
results are very similar to those described in refs. 10 and 11 for intact
GroEL. The rate constants (in units of min21) for the exchange of
individual NH protons in barnase in the presence of fragment [kex
obs
(1G)] are plotted against those in the absence (kex
obs). Amide protons
that exchange by global, mixed, and local unfolding mechanisms are
displayed by circles, triangles, and squares, respectively. The plot for 90
mM sht-GroEL191-345 at pD 7.1 (not shown) is virtually superimposable
on that for sht-GroEL191-376 (b). (pD 5 pH measured in 2H2O.) It is
clearly seen that those protons that require global unfolding for exchange
have significantly increased rates, thus showing that the fragments bind to
the unfolded state of barnase and catalyze its unfolding. We could only
estimate the final concentration ofGroEL fragment in a sinceGroEL191-
345 tended to crystallize during the exchange experiment at the high
initial protein concentration.
FIG. 3. Refolding of rhodanese and cyclophilin A in the presence
of sht-GroEL191-345 and sht-GroEL191-376. (a) Relative enzymatic
activity of rhodanese (0.1 mM) after refolding in the presence (1) or
absence (2) of GroEL (2.5 mM monomer), GroES (2.5 mM mono-
mer), ATP (2 mM), sht-GroEL191-345 (2.5 mM), sht-GroEL191-376
(2.5 mM), or bovine serum albumin (45 mgyml), from 8 M urea (U).
One-hundred percent activity was obtained with native rhodanese (N).
(b) Refolding kinetics of rhodanese in presence of GroEL, GroES, and
ATP. The final concentrations are the same as in a. One-hundred
percent activity was obtained with native rhodanese. (c and d)
Refolding kinetics of rhodanese in the presence of 0.18 mM, 2.5 mM,
or 5 mM sht-GroEL191-345 and sht-GroEL191-376, respectively. (e)
Refolding of 1 mM cyclophilin A in the presence of 7 mM GroEL
(monomer), 4 mM sht-GroEL191-345, 4 mM sht-GroEL191-376, or 1
mM sht-GroEL191-376. One-hundred percent activity was obtained
with native cyclophilin A. Standard error bars are shown. The 30%
spontaneous refolding of cyclophilin was complete in the dead time of
the experiment.
15026 Biochemistry: Zahn et al. Proc. Natl. Acad. Sci. USA 93 (1996)
histidine-tail did not abolish binding activity. The mechanism
of exchange at pD 6.6 is EX2, but changes to EX1 at higher pD
(33). We can estimate the rate constant for dissociation of
barnase from the apical domain as 2 s21, which is less than
5-fold larger than that from intact GroEL (10, 11).
Chaperone activity was confirmed directly from studies on
rhodanese, which refolds in high yield in vitro only in the
presence of GroEL, ATP, and the co-chaperonin GroES (Fig.
3a and refs. 30, 34, and 35). In the absence of GroES,
rhodanese dissociates from nucleotide-ligated GroEL in a
non-native state and aggregates (35). Sht-GroEL191-376 and
sht-GroEL191-345 facilitate refolding of rhodanese in the
absence of additional cofactors (Fig. 3a), indicating a transient
binding of the GroEL fragments to the aggregation-prone
intermediates during refolding of rhodanese, which prevents
aggregation. The effect of the GroEL-fragments on refolding
yield of rhodanese is lowered in the presence of GroES (Fig.
3a), indicating a competition between rhodanese and the
co-chaperonin for binding to the apical domain or its truncated
form. Interestingly, the refolding of rhodanese in the presence
of sht-GroEL191-345 (Fig. 3c) or sht-GroEL191-376 (Fig. 3d)
has a similar rate constant to that in the presence of GroEL,
GroES, and ATP (Fig. 3b), the half time of refolding being
about 15 min. Thus, the affinity of rhodanese for the apical
domain seems to be similar to that of GroEL in the presence
of GroES and ATP. The rate constant of refolding does not
depend on the concentration of apical domain (Fig. 3 c and d),
indicating that the rate-limiting step for refolding of rhodanese
occurs in the complex. The refolding yield of rhodanese is
generally lower in the presence of apical domain than in the
presence of GroEL, GroES, and ATP (3 b and c), and the
truncated domain is more active than the full length (3 b–d).
The yield on refolding is maximal at molar ratios of apical
domain to rhodanese of .1 because the binding is not suffi-
ciently strong, so that there is not complete association, and we
estimate a dissociation equilibrium constant of .1027 M. We
also tested the chaperone activity of sht-GroEL191-345 and
sht-GroEL191-376 for a second protein. Cyclophilin A refolds
only at low yield in the absence of chaperone (Fig. 3e), but
refolding is facilitated in the presence of GroEL owing to
transient complex formation (Fig. 3e) (36). There are similar
rate constants for refolding of cyclophilin A in the presence of
intact GroEL and in the presence of GroEL fragments, which
within a factor of four do not depend on chaperone concen-
tration (Fig. 3e). Maximal refolding yield was obtained at
stoichiometric concentrations of cyclophilin A and apical
domain, indicating the formation of a 1:1 complex between
chaperone fragment and substrate protein during refolding.
Flexibility of C-Terminal Helices. The apical domain and
the fragment truncated at position 345 are reversibly dena-
tured by temperature or urea, and the denaturation is not
influenced by the N-terminal histidine-tail. There are two
cooperative folding transitions, at 348C and 678C, during the
thermal denaturation of sht-GroEL191-376, measured by far
UV-CD (Fig. 4a), indicating the existence of two independent
folding units within the apical domain. There is only one
transition for unfolding of sht-GroEL191-345, at 678C. At
458C, the CD spectrum of the apical domain is identical to that
of the truncated domain. The C-terminal a-helices must
therefore melt at the lower temperature and separately from
the ‘‘domain core.’’ The second cooperative transition associ-
ated with the extra 31 amino acids in sht-GroEL191-376 was
confirmed by differential scanning calorimetry (Fig. 4b). The
calorimetric data are also essentially consistent with the un-
folding of the apical domain as a monomer. At physiological
temperature, about 50% of helices H11 and H12 are in an
unfolded conformation, and thus flexible.
Three-Dimensional Structure of the Domain Core. The
crystallographic data are in Table 1 and the coordinates are
deposited in the Brookhaven data base with the reference
1JON. Overall, sht-GroEL191-345 has the same fold as the
corresponding region of the intact GroEL protein (Fig. 5Upper
Left): two orthogonal b-sheets forming a b-sandwich, f lanked
by three a-helices. The structure is more ordered and better
resolved than is the apical domain of the intact protein (Fig.
5 Upper Right): the average B factor is 42 Å2, compared with
97 Å2 for residues 191–336 of the GroEL structure. Unfortu-
nately, such unusually high disorder in the GroEL structure
complicates the interpretation of a structural comparison, in
the same way as it can be misleading to use an average of NMR
structures for comparison with a crystal structure, and so we
have not done so here. In essence, the structure can be
described as a well-ordered b-sandwich scaffold, f lanked by
FIG. 4. Thermal denaturation of sht-GroEL191-376 (upper trace)
and of sht-GroEL191-345 (lower trace). (a) Monitored by far UV-CD
at 222 nm. (b) Monitored by differential scanning calorimetry.
Table 1. Summary of crystallographic data
Data collection statistics






Completeness of data (%)* 99.4 (96.7)





R factoryfree R factor (%), F . 0‡ 21.4y29.1
rmsd bond length, Å 0.006
rmsd bond angle, deg 1.42
rmsd, Root-mean-square deviation.
*Values given in parenthesis are for the highest resolution shell.
†Agreement between intensities of repeated measurements of the
same reflections and can be defined as: ¥ (Ih,i 2 ^Ih&)y¥ Ih,i, where
Ih,i are individual values and ^Ih& is the mean value of the intensity of
reflection h.
‡The free R factor was calculated with the 10% data omitted from the
refinement [test set, prepared using DATAMAN (40), using RFree
SPhere option].
Biochemistry: Zahn et al. Proc. Natl. Acad. Sci. USA 93 (1996) 15027
relatively flexible helical and loop regions. In particular, the B
factors of most of the b-strand, a-helix, and loop structure are
about 20, 40, and 60 Å2, respectively (Fig. 5 Upper Right). The
quality of the electron density map is shown in Fig. 5 Lower.
There are two regions of considerable disorder. First, electron
density is not found for the C-terminal residues 337–345, which
correspond to the first half of a-helix H11. This is in agreement
with the results from folding experiments, described above.
Second, electron density for residues 302–307 is very poor and
fragmented. This region is part of the most disordered segment
in the structure of intact GroEL (3).
DISCUSSION
The apical domain of GroEL can be expressed as a stable
protein and with high yield in E. coli, allowing its activity,
folding, and structure to be studied separately from those of
the equatorial and intermediate domains. The isolated, apical
domain is functional in polypeptide binding (Fig. 2), and it
facilitates protein folding, especially when truncated to remove
its C-terminal a-helices, H11 and H12 (Fig. 3). Point mutagen-
esis studies support the passive role of the C-terminal part of
the apical domain in polypeptide binding (4). The isolated
apical domain and its active fragments thus function as
“minichaperones.” The apical domain slows down refolding of
cyclophilin by more than 10-fold (Fig. 3), and the folding of
rhodanese is significantly more retarded by the minichaper-
ones than by the longer proteolytic fragments of Yoshida et al.
(16, 17). The increase in the yield of refolding of rhodanese and
cyclophilin A in the presence of apical domain (Fig. 3), which
is too small to reassociate and to form a cavity, clearly
demonstrates the presence of an intrinsic chaperone activity in
GroEL, which is independent of a central cavity. This is in
agreement with the NMR experiments on barnase in the
presence of apical domain (Fig. 2). The presence of mM
concentrations of GroEL considerably broadens the resonance
lines of barnase owing to fast association and dissociation of
native barnase from the slowly tumbling GroEL (10, 11). If the
apical domain and barnase formed a complex of large molec-
ular size, e.g., containing 7 or 14 molecules of apical domain,
one would expect a considerable degree of line broadening in
the NMR spectra of barnase in the presence of apical domain.
This is not observed at 8-fold higher concentration of apical
domain than of GroEL (expressed inmonomers). The complex
between apical domain and barnase seems, therefore, to be of
low molecular weight and probably has a 1:1 stoichiometry,
which would be consistent with the binding stoichiometry of
the apical domain and cyclophilin A (Fig. 3e).
The intrinsic chaperone activity of monomeric apical do-
main raises two interrelated questions: how does the fragment
facilitate refolding of rhodanese when, at physiological con-
ditions, GroES and ATP are required in the presence of intact
GroEL; and what is the role of the central cavity? The role of
GroES appears to be to weaken the affinity of GroEL for
substrates, and to prevent premature dissociation of aggrega-
tion prone states: there has to be a balance between tight
binding for the annealing activity and weaker binding to allow
folding. The weaker binding of rhodanese to the fragment must
be adequate for chaperoning activity and weak enough to allow
folding (15). This is in agreement with the finding of similar
rate constants for refolding of rhodanese in the presence of
apical domain and in the presence of GroEL, GroES, and ATP
(Fig. 3 b–d). The complex structure of GroEL and the mod-
ulation of its substrate affinity by GroES and nucleotides must
be to allow the efficient folding of a wide range of proteins,
with a wide variation of affinities for GroEL. Although the
central cavity is clearly not essential for the refolding of
cyclophilin A and rhodanese, it could still be important for
refolding in vivo.
Helices H11 and H12 are much less stable than the domain
core of the apical domain, and form a separate folding unit
(Fig. 4). At physiological temperature, about 50% of the
secondary structure of the low-melting helices is unfolded and
thus becomes flexible. But, in vivo, the C terminus is not
degraded, implying that the primary structure is not accessible
to degradation by E. coli proteases. The low stability of the
C-terminal helices may allow movement of the domain cores
within the GroEL-ring. This f lexible arrangement of the apical
domainmay be involved in the cooperative binding of unfolded
polypeptide to the seven subunits of GroEL in each ring.
GroEL is known to bind to at least half of E. coli proteins in
their denatured states (39). It is thus likely that flexibility is
required to bind a large variety of proteins with different
primary, secondary, and tertiary structures. The low stability
of the C terminus may also contribute to the large conforma-
tional change in GroEL on binding of GroES, which has been
suggested to occur by rigid body movement through the
b-sheet hinge region of the intermediate domain (2).
The production and crystallization of monomeric fragments
of the apical domain has allowed us to determine the three-
dimensional structure of the polypeptide binding part of
GroEL with B factors much lower than those for the equivalent
regions in GroEL (Fig. 5) (2, 3, 6), perhaps because of
favorable packing interactions within the crystal, or the ab-
sence of static disorder that is present in crystals of intact
GroEL, or a combination of both. The crystals of the
minichaperone may provide a suitable paradigm for detailed
studies of peptide–GroEL interactions.
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